1. Home
  2. INLX vs TXMD Comparison

INLX vs TXMD Comparison

Compare INLX & TXMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Intellinetics Inc.

INLX

Intellinetics Inc.

N/A

Current Price

$5.15

Market Cap

25.5M

Sector

Technology

ML Signal

N/A

Logo TherapeuticsMD Inc.

TXMD

TherapeuticsMD Inc.

N/A

Current Price

$2.03

Market Cap

24.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
INLX
TXMD
Founded
1996
2008
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
25.5M
24.3M
IPO Year
2013
2012

Fundamental Metrics

Financial Performance
Metric
INLX
TXMD
Price
$5.15
$2.03
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
3.7K
★ 17.3K
Earning Date
11-05-2026
11-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 73.68
EPS
N/A
★ 0.02
Revenue
$11,336.00
★ $1,761,000.00
Revenue This Year
$14.57
$207.74
Revenue Next Year
N/A
$2.15
P/E Ratio
★ N/A
$102.00
Revenue Growth
N/A
★ 35.25
52 Week Low
$5.00
$0.99
52 Week High
$11.75
$2.95

Technical Indicators

Market Signals
Indicator
INLX
TXMD
Relative Strength Index (RSI) N/A 39.02
Support Level N/A $2.00
Resistance Level N/A $2.15
Average True Range (ATR) 0.00 0.06
MACD 0.00 -0.02
Stochastic Oscillator 0.00 0.00

Price Performance

Historical Comparison
INLX
TXMD

About INLX Intellinetics Inc.

Intellinetics Inc is a document service and solutions software company serving both the small-to-medium business and governmental sectors. The company's digital transformation products and services are provided through two reporting segments: Software and Document Services. The Software segment consists of solutions involving software platforms, which allow customers to capture and manage all documents across operations such as scanned hard-copy documents and all digital documents including those from Microsoft Office 365, digital images, audio, video, and emails. The company's Document Services offerings aid clients as a part of their overall document to convert documents from one medium to another. Majority of revenue is from Document Services Segment.

About TXMD TherapeuticsMD Inc.

TherapeuticsMD Inc is a pharmaceutical royalty company that owns and manages intellectual property, including trademarks and product rights, which are licensed to third-party pharmaceutical companies. The company generates revenue mainly through royalties and milestone payments from licensed products, including IMVEXXY, BIJUVA, and ANNOVERA, and does not directly manufacture or market pharmaceutical products.

Share on Social Networks: